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Introduction: Mycotoxin binders
• Feed additive: as mycotoxin binder
Recommended level: 1 – 2 g/kg (0.1% - 0.2%)
• Feed additive: for technological purposes
Maximally 20 g bentonite/kg feed (2%)
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Introduction: Doxycycline (DOX)
• Tetracycline antibiotic
• Mycoplasma spp., Actinobacillus pleuropneumoniae, 
Bordetella bronchiseptica, etc.
• Oral bioavailability is lower in fed animals
(ESVAC, 2016)
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Aims
Mycotoxin binders: feed additives Antimicrobials (doxycycline):
Oral administration via feed/drinking water
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Experiment 1: Study design
Blood sampling at different time points after DOX administration
LC-MS/MS analysis of DOX in plasma
Comparing PK
Fasted animals, single oral bolus: 
- Daily dosis of mycotoxin binder (~0.2% inclusion rate)
- DOX (10 mg/kg BW)
Control Clay 1 Clay 2 Clay 3 Yeast 1
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Experiment 1: Results
Treatment group Control Clay 1 Clay 2 Clay 3 Yeast 1
AUC0-12h (h·µg/mL) 9.60 ± 3.49 12.29 ± 4.57 9.73 ± 2.35 6.37 ± 2.63 10.72 ± 5.59
AUC0-inf (h·µg/mL) 10.56 ± 3.97 12.90 ± 4.84 10.43 ± 2.42 7.54 ± 2.67 11.78 ± 6.04
Relative F (%) 100.00 ± 37.61 122.31 ± 45.87 98.91 ± 22.95 71.50 ± 25.34 111.69 ± 57.28
Tmax (h) 2.00 ± 1.10 2.83 ± 1.47 2.50 ± 1.64 2.17 ± 1.47 2.50 ± 1.22
Cmax (µg/mL) 2.01 ± 0.91 2.46 ± 0.90 2.12 ± 0.77 1.31 ± 0.75 1.93 ± 1.06
kel (1/h) 0.23 ± 0.08 0.29 ± 0.05 0.22 ± 0.04 0.21 ± 0.13 0.23 ± 0.06
T1/2el (h) 4.83 ± 1.74 3.57 ± 0.52 4.69 ± 0.87 6.59 ± 3.95 4.60 ± 1.11
Vd/F (L/kg) 4.77 ± 1.35 3.07 ± 1.12 4.66 ± 1.14 9.26 ± 5.81 5.36 ± 3.92
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Experiment 2: Study design
Blood sampling at different time points after DOX administration
LC-MS/MS analysis of DOX in plasma
Comparing PK
Fasted animals, single oral bolus: 
- Daily dosis of mycotoxin binder (~1% inclusion rate)
- DOX (10 mg/kg BW)
Control Clay 1 Clay 3
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Experiment 2: Results
Treatment group Control Clay 1 Clay 3
AUC0-12h (h·µg/mL) 9.60 ± 3.49 2.26 ± 2.16* 1.49 ± 0.94†
AUC0-inf (h·µg/mL) 10.56 ± 3.97 2.28 ± 2.55* 2.07 ± 1.02*
Relative F (%) 100.00 ± 37.61 21.62 ± 24.14* 19.67 ± 9.64*
Tmax (h) 2.00 ± 1.10 4.50 ± 2.07 4.50 ± 3.83
Cmax (µg/mL) 2.01 ± 0.91 0.45 ± 0.40* 0.32 ± 0.21*
kel (1/h) 0.23 ± 0.08 0.33 ± 0.16 0.15 ± 0.06
T1/2el (h) 4.83 ± 1.74 3.44 ± 1.19 7.44 ± 2.44
Vd/F (L/kg) 4.77 ± 1.35 26.77 ± 18.28 45.46 ± 32.81‡
Cl/F (L/h/kg) 1.09 ± 0.46 8.16 ± 4.80‡ 6.11 ± 3.51‡
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Experiment 3: Study design
Blood sampling at different time points after DOX administration
LC-MS/MS analysis of DOX in plasma
Comparing PK
Continuous administration in the feed: 
- Mycotoxin binder (0.2% inclusion rate)
- DOX: 270 mg/kg feed (~10 mg/kg BW)
Control Clay 1 Clay 2 Clay 3 Yeast 1
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Experiment 3: Results
Treatment Control Clay 1 Clay 2 Clay 3 Yeast 1
Css (ng/mL) 143.02± 29.48 144.46 ± 24.32121.50 ± 28.53127.86 ± 15.89137.23 ± 27.37




97.82 ± 21.87 82.43 ± 18.95 83.11 ± 14.54 92.10 ± 13.28
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Discussion & Conclusions
• Interaction possible at high dose, in fasted animals
• No interactions observed at low dose
• Confirms in vitro results using feed containing buffered matrix 
(Poster 17)
• Bolus model screening
• EFSA (2010)
– Highest recommended dose
– Steady state design: veterinary medicinal product in feed, 5 
days sampling
• Further information
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